const strengths = [
  {
    title: "Nutraceuticals",
    points: [
      "Formulation of Nutraceutical products",
      "Biological characterization of the nutraceuticals",
      "Isolation and characterization of the key constituents from the plant source",
    ],
    url: "/strength/nutraceuticals",
  },
  {
    title: "Drug Design and Synthesis (New Chemical Entities)",
    points: [
      "Bioinformatics",
      "Drug designing",
      "Drug repurposing",
      "Lead enrichments ",
      "Pesticides designing",
      "Structural Bioinformatics",
      "Structural Pharmacogenomics",
      "Analog designing",
      "Library of molecules",
    ],
    url: "/strength/drug-design-and-synthesis",
  },
  {
    title: "Active Pharmaceutical Ingredient (API) Development",
    points: [
      "Process development of existing drug candidates using cost effective synthetic methods",
      "Production of bioorganic/biosynthetic compounds using microbes and natural flora/fermentation",
      "Scale up of process from small to pilot",
      "Synthesis of fine chemicals",
      // "Patents",
    ],
    url: "/strength/api-development",
  },
  {
    title: "Natural Product Chemistry",
    points: [
      "Extraction of plant constituents",
      "Isolation of active phytoconstituents",
      "Characterization of phytoconstituents using sophisticated instruments such as RP-HPLC, UHPLC, GC-MS and UPLC-QqQ â€“MS/MS",
      "Standardization and quality control of medicinal plants/formulations",
      "Validation of raw drugs",
      "Molecular interaction analysis of phytoconstituents on cancer receptors by in <i>silico</i> methods",
      "Drug Binding properties of phytoconstituent on Human serum albumin",
    ],
    url: "/strength/natural-product-chemistry",
  },
  {
    title: "Formulation Development and Evaluation",
    points: [
      "Conventional dosage forms (solid orals, liquid orals)",
      "Nanoparticles/Nano formulation",
      "Herbal formulation",
    ],
    url: "/strength/formulation-development-and-evaluation",
  },
  {
    title: "Analytical Division",
    points: [
      "Analytical method development and validation for API",
      "Analytical method development and validation for biological products",
      "Analytical method development and validation for pharmaceuticals and nutraceuticals",
      "Quality by Design (QbD) approach",
      "Evaluation of finished pharmaceuticals and nutraceuticals",
      "Spectral studies (UV, FTIR, NMR, Mass)",
    ],
    url: "/strength/analytical-division",
  },
  {
    title: "Preclinical Studies",
    points: [
      "<i>In vitro</i> assay",
      "Cell line studies",
      "<i>In vivo</i> animal experiments",
      "<i>Ex vivo</i> studies",
      "Pharmacokinetic studies",
    ],
    url: "/strength/preclinical-studies",
  },
  {
    title: "BA/BE",
    points: ["Bioavailability studies", "Bioequivalence studies"],
    url: "/strength/ba-be",
  },
  {
    title: "Cancer Research",
    points: [
      "Screening of lead molecules using zymography/migration/viability/phosphorylation assays (Bioassay guided fractionation) to develop newer TKIs",
      "Assessing the efficacy of indigenous herbs or isolated molecules using cell based model systems.",
      "Validation of the efficacy of herbs using real time polymerase chain reaction to assess gene expression, immunofluorescence, zymography and western blot analysis",
      "Development of a cell line derived xenograft to ascertain in vivo effects of lead molecules",
      "Development of a tumor in dish model for personalized therapy",
    ],
    url: "/strength/cancer-research",
  },
];
export default strengths;
